Koichi Tanabe

Koichi Tanabe

UNVERIFIED PROFILE

Are you Koichi Tanabe?   Register this Author

Register author
Koichi Tanabe

Koichi Tanabe

Publications by authors named "Koichi Tanabe"

Are you Koichi Tanabe?   Register this Author

36Publications

-Reads

FK506 resistance of Pdr5 and Cdr1 involves mutations in the transmembrane domains and extracellular loops.

Antimicrob Agents Chemother 2018 Oct 22. Epub 2018 Oct 22.

Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, New Zealand

View Article
October 2018

Monitoring of Iron Depletion-Induced Mitophagy in Pathogenic Yeast.

Methods Mol Biol 2018 ;1759:161-172

Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.

View Article
January 2018

Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice.

Biochem Biophys Rep 2017 Dec 13;12:166-171. Epub 2017 Oct 13.

Department of Chemotherapy and Mycosis, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.

View Article
December 2017

Iron-depletion promotes mitophagy to maintain mitochondrial integrity in pathogenic yeast Candida glabrata.

Autophagy 2016 08 27;12(8):1259-71. Epub 2016 Jun 27.

a Department of Chemotherapy and Mycoses , National Institute of Infectious Diseases , Shinjuku-ku , Tokyo , Japan.

View Article
August 2016

Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.

J Infect Chemother 2015 Dec 23;21(12):831-6. Epub 2015 Oct 23.

Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan. Electronic address:

View Article
December 2015

The mannoprotein TIR3 (CAGL0C03872g) is required for sterol uptake in Candida glabrata.

Biochim Biophys Acta 2015 Feb 11;1851(2):141-51. Epub 2014 Nov 11.

Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Japan. Electronic address:

View Article
February 2015

Potent drugs that attenuate anti-Candida albicans activity of fluconazole and their possible mechanisms of action.

J Infect Chemother 2014 Oct 5;20(10):612-5. Epub 2014 Jul 5.

Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan.

View Article
October 2014

Genome-wide survey of transcriptional initiation in the pathogenic fungus, Candida glabrata.

Genes Cells 2014 Jun 14;19(6):478-503. Epub 2014 Apr 14.

Department of Electronic and Information Engineering, Suzuka National College of Technology, Shiroko, Suzuka, Mie 510-0294, Japan.

View Article
June 2014

Detection of environmental sources of Histoplasma capsulatum in Chiang Mai, Thailand, by nested PCR.

Mycopathologia 2013 Dec 13;176(5-6):395-402. Epub 2013 Sep 13.

Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.

View Article
December 2013

Application of nested PCR for diagnosis of histoplasmosis.

J Infect Chemother 2013 Oct 24;19(5):999-1003. Epub 2013 Jan 24.

Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan,

View Article
October 2013

The Candida glabrata sterol scavenging mechanism, mediated by the ATP-binding cassette transporter Aus1p, is regulated by iron limitation.

Mol Microbiol 2013 Apr 11;88(2):371-81. Epub 2013 Mar 11.

Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.

View Article
April 2013

Serum cholesterol promotes the growth of Candida glabrata in the presence of fluconazole.

J Infect Chemother 2013 Feb 12;19(1):138-43. Epub 2012 Dec 12.

Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.

View Article
February 2013

Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function.

Mol Microbiol 2011 Oct 19;82(2):416-33. Epub 2011 Sep 19.

Department of Bioactive Molecules, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.

View Article
October 2011

Growth defects resulting from inhibiting ERG20 and RAM2 in Candida glabrata.

FEMS Microbiol Lett 2011 Apr 31;317(1):27-33. Epub 2011 Jan 31.

Faculty of Pharmaceutical Science, Suzuka University of Medical Science, Suzuka, Mie, Japan.

View Article
April 2011

Serum or bile affects the in vitro azole susceptibilities of Candida spp.

Jpn J Infect Dis 2009 Jul;62(4):306-8

Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.

View Article
July 2009

Efflux-mediated antifungal drug resistance.

Clin Microbiol Rev 2009 Apr;22(2):291-321, Table of Contents

Department of Oral Sciences, School of Dentistry, University of Otago, P.O. Box 647, Dunedin 9054, New Zealand.

View Article
April 2009

[What's new in the molecular basis of antifungal drug resistance in pathogenic yeasts].

Nihon Rinsho 2008 Dec;66(12):2273-8

Department of Bioactive Molecules, National Institute of Infectious Diseases.

View Article
December 2008

ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.

Antimicrob Agents Chemother 2008 Nov 18;52(11):3851-62. Epub 2008 Aug 18.

Department of Oral Sciences, School of Dentistry, University of Otago, Dunedin, New Zealand.

View Article
November 2008

The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum.

J Antimicrob Chemother 2007 Dec 2;60(6):1264-72. Epub 2007 Oct 2.

Department of Chemistry and Biochemistry, Suzuka National College of Technology, Shiroko, Suzuka, Mie 510-0294, Japan.

View Article
December 2007

Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium.

Biochem Biophys Res Commun 2007 Dec 29;364(4):990-5. Epub 2007 Oct 29.

Department of Bioactive Molecules, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.

View Article
December 2007

Candida albicans drug resistance another way to cope with stress.

Microbiology 2007 Oct;153(Pt 10):3211-7

Department of Oral Sciences, University of Otago, Dunedin 9054, New Zealand.

View Article
October 2007

Amino acid residues affecting drug pump function in Candida albicans--C. albicans drug pump function.

Nihon Ishinkin Gakkai Zasshi 2006 ;47(4):275-81

Department of Oral Sciences, School of Dentistry, University of Otago, Dunedin, New Zealand.

View Article
February 2007

[ABC transporters of pathogenic fungi: recent advances in functional analyses].

Nihon Ishinkin Gakkai Zasshi 2005 ;46(4):249-60

Department of Bioactive Molecules, National Institute of Infectious Diseases, Tokyo, Japan.

View Article
January 2006

Characterization of the Saccharomyces cerevisiae sec6-4 mutation and tools to create S. cerevisiae strains containing the sec6-4 allele.

Gene 2005 Nov 26;361:57-66. Epub 2005 Sep 26.

University of Otago, Department of Oral Sciences, PO Box 647, Dunedin 9001, New Zealand.

View Article
November 2005

Phosphorylation of candida glabrata ATP-binding cassette transporter Cdr1p regulates drug efflux activity and ATPase stability.

J Biol Chem 2005 Jan 21;280(1):94-103. Epub 2004 Oct 21.

Department of Bioactive Molecules, National Institute of Infectious Diseases, 1-23-1 Toyama, Shin-juku-ku, Tokyo 162-8640, Japan.

View Article
January 2005

Candida albicans protein kinase CaHsl1p regulates cell elongation and virulence.

Mol Microbiol 2005 Jan;55(2):381-95

Department of Bioactive Molecules, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, Japan.

View Article
January 2005